Source: British Journal of Pharmacology. Unidade: FMRP
Subjects: ADJUVANTES IMUNOLÓGICOS, ÓXIDO NÍTRICO, MEDULA ÓSSEA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GASPAR-ELSAS, Maria Ignez et al. α-Galactosylceramide suppresses murine eosinophil production through interferon-γ-dependent induction of NO synthase and CD95. British Journal of Pharmacology, v. 172, n. 13, p. 3313-3325, 2015Tradução . . Disponível em: https://doi.org/10.1111/bph.13126. Acesso em: 28 maio 2024.APA
Gaspar-Elsas, M. I., Queto, T., Masid-de-Brito, D., Vieira, B. M., Luca, B. de, Cunha, F. de Q., & Xavier-Elsas, P. (2015). α-Galactosylceramide suppresses murine eosinophil production through interferon-γ-dependent induction of NO synthase and CD95. British Journal of Pharmacology, 172( 13), 3313-3325. doi:10.1111/bph.13126NLM
Gaspar-Elsas MI, Queto T, Masid-de-Brito D, Vieira BM, Luca B de, Cunha F de Q, Xavier-Elsas P. α-Galactosylceramide suppresses murine eosinophil production through interferon-γ-dependent induction of NO synthase and CD95 [Internet]. British Journal of Pharmacology. 2015 ; 172( 13): 3313-3325.[citado 2024 maio 28 ] Available from: https://doi.org/10.1111/bph.13126Vancouver
Gaspar-Elsas MI, Queto T, Masid-de-Brito D, Vieira BM, Luca B de, Cunha F de Q, Xavier-Elsas P. α-Galactosylceramide suppresses murine eosinophil production through interferon-γ-dependent induction of NO synthase and CD95 [Internet]. British Journal of Pharmacology. 2015 ; 172( 13): 3313-3325.[citado 2024 maio 28 ] Available from: https://doi.org/10.1111/bph.13126
